The University of Oxford’s Oxford Vaccine Group has launched the world’s first Phase I clinical trial, BD-Ebov, of a vaccine against Bundibugyo ebolavirus (BDBV), in response to the ongoing outbreak in the Democratic Republic of the Congo and neighbouring Uganda. Conducted in Oxford, the trial will assess the safety and immune response of the ChAdOx1 BDBV vaccine…
By Ridwan Oyenuga, Founder & CEO, SereniMind A child stops eating lunch at school. Her teacher notices but says nothing — children sometimes go through phases. Her mother notices she has stopped talking at dinner but attributes it to teenage moodiness. Her father notices she flinches at loud sounds but puts it down to sensitivity.…
Activity Overview On 10 June 2026, the Health Journalists Network in Uganda (HEJNU), convened a one-day Media Science Café in Kampala to strengthen journalists’ understanding of safe abortion, post-abortion care, and sexual and reproductive health and rights (SRHR). The session was presided over by HEJNU Team Leader Esther Nakkazi and Joy Namugembe, and coordinated by…
Date: 15 June 2026 Venue: Kampala Organizer: Health Journalists Network in Uganda (HEJNU) On 15 June 2026, the Health Journalists Network in Uganda (HEJNU) convened a one-day Media Science Café in Kampala to strengthen journalists’ understanding of sexual and reproductive health and rights, with particular focus on safe abortion, post-abortion care, and the public health…
Health Journalism Network Uganda (HEJNU) health Café in Gulu City. On June 23rd, 2026, the Health Journalism Network Uganda (HEJNU), with support from Coalition for Health Promotion and Social Development (HEPS Uganda) held a health media café at the Northern Uganda Media Club (NUMEC), Gulu City on “The roll out of Lenacapavir amid HIV situation in…
Activity Overview On 17 June 2026, the Health Journalists Network in Uganda (HEJNU), with support from HEPS Uganda, convened a Media Science Café in Kampala to strengthen journalists’ understanding of the latest evidence on Lenacapavir (LEN) and its role in HIV prevention. The session was presided over by HEJNU Team leader Esther Nakkazi and coordinated…
On 19 June 2026, the Health Journalists Network in Uganda (HEJNU), with support from HEPS Uganda, convened a Media Science Café at Oxford Hotel in Mbarara City. The half-day engagement brought together journalists from print, radio, television, and online media across the Ankole Sub-region to strengthen their understanding of Lenacapavir (LEN), Uganda’s newest long-acting HIV…
Activity Overview On 19 June 2026, the Health Journalists Network in Uganda (HEJNU), with support from HEPS Uganda, convened a half-day Media Science Café at Court Lane Hotel in Masaka City. The café brought together 21 journalists from radio, television, print, online, and digital media across the Greater Masaka region to strengthen their understanding of…
Malik Fahad, Masaka region Masaka region has rolled out the use of injectable Lenacapavir (LEN) amidst a call for behavior change as a preventive measure in the fight against HIV. Addressing journalists in Masaka during a media science cafe organized by Health Journalists Network Uganda -HEJNU to sensitize journalists in the region about the injectable…
HEJNU Media Science Café funded by CATALYTIC Fund (IPAS) On 26 May 2026, the Health Journalists Network in Uganda (HEJNU) convened a one-day Media Science Café in Kampala sponsored by the CATALYTIC Fund to strengthen journalists’ understanding and reporting of sexual and reproductive health and rights (SRHR). The session was opened by HEJNU Founder/President Esther…